Prestige Consumer Healthcare Inc. Reports Fiscal 2021 First Quarter Results
06. August 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue was $229.4 Million in First Quarter Fiscal 2021, Down 0.6% from Prior Year Q1 Excluding Unfavorable Foreign CurrencyDiluted EPS of $0.86 in First Quarter Fiscal 2021, up 32% from Prior Year...
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results
13. Juli 2020 16:45 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results
07. Mai 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1 Million and Adjusted Free...
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Fourth Quarter and Year-End Earnings Results
27. April 2020 08:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 27, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 fourth quarter and year-end earnings release on...
Prestige Consumer Healthcare Inc. Announces New $25 Million Share Repurchase Program, Participation in the Raymond James Institutional Investors Conference
02. März 2020 06:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., March 02, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that the Company’s Board of Directors authorized the repurchase of up to $25.0...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Third Quarter and Year-to-Date Results
06. Februar 2020 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue $241.6 Million in Q3 Fiscal 2020; Organic Revenue up 0.5% versus Prior Year Q3GAAP Diluted EPS of $0.75 in Q3 Fiscal 2020; Adjusted EPS of $0.81, Up 11% Versus Prior Year Q3Year-to-date Cash...
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results
06. Januar 2020 18:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 third quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes
15. November 2019 16:15 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
15. November 2019 07:35 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Second Quarter and Year-to-Date Results
31. Oktober 2019 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue $238.1 Million in Q2 Fiscal 2020; Organic Revenue FlatGAAP Diluted EPS of $0.65 in Q2 Fiscal 2020; Adjusted EPS of $0.68, Up 5% Versus Prior Year Q2Cash Flow From Operations of $50.2 Million;...